According to a research report titled ‘Global Periodontal Market 2019-2028’, available with Market Study Report, global periodontal market is expected to witness a compound annual growth rate of 7.79% over the forecast period 2019-2028.
 

Growing geriatric population and rising number of edentulous individuals are stimulating worldwide periodontal market development. Furthermore, growth in medical tourism coupled with the ongoing technological developments are generating substantial growth opportunities in this business sphere.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552618/
 

On the other hand, high costs of periodontal surgery and dearth of proper diagnosing mechanisms for treatment are restraining the market progress. Moreover, lack of emphasis on dental care among the general public and issues faced with reimbursement policies are negatively impacting the industry’s growth trajectory.
 

Based on treatment type, global periodontal market is classified into non-surgical treatment [therapy {local antibiotics (arestin, others), systemic antibiotics (minocycline, doxycycline, others)}, laser treatment], surgical devices [dental bone implants (subperiosteal, endosteal), dental bone grafting (allograft, xenograft, other bone grafting)], and others
 

Moving on to end-user spectrum, the industry segmentation comprises dental clinics and laboratories, dental research institutes, hospitals, and other end-users.
 

From a regional frame of reference, Asia-Pacific periodontal market is slated to record a strong growth rate over the analysis timeframe. This can be credited to rise in disposable income levels and changing consumer lifestyles in the region.
 

China is slated to be a major revenue generator for the industry owing to rising incidence of oral health issues due to prevalence non-communicable diseases. In addition, escalating number of private dental clinics is enhancing the industry outlook in such countries. Furthermore, surging demand for reimbursement insurance, and growing requirement of more dental programs for consumers is encouraging private insurance and dental health companies to enter the Chinese market.
 

Prominent industry players are Danaher Corp., Medtronic plc, Apteryx Imaging Inc. (Planet DDS), Henry Schein Inc., Dexcel Pharma Technologies Ltd., Dentsply Sirona Inc., Young Innovations Inc., 3M Company, DenMat Holdings LLC, Biolase Inc., Straumann AG, Bausch Health Companies Inc., Oral Science Inc., Zimmer Biomet Holdings Inc., and Ultradent Products Inc.